New starter at Bind

May 1, 2026

Bind

We’re happy to share that Rashik Aryal, MSc is the latest addition to the Bind Research family!

Rashik joins us as Research Assistant, bringing a genuinely multidisciplinary background, from clinical diagnostics to genetic engineering to early-stage protein research.

Rashik will be supporting Bind across protein expression and characterisation workflows, while also helping us develop rigorous, scalable lab operations. Both fundamental to Bind’s success!

Welcome, Rashik — we’re really glad to have you on board.

More News & Insights

News updates

Bind joins the Milner Bio-Incubator

Bind Research is joining the buzzing Cambridge scene! We have opened a satellite lab within the Milner Bio-Incubator at the Milner Therapeutics Institute in Cambridge. The Milner was set up to bridge academia and industry in drug discovery, bringing together its own research programme in functional genomics and target discovery with a consortium of pharma […]

20 May 2026

News updates

Mark Murcko appointed to Board of Directors and Lead Scientific Advisor

We’re delighted to welcome Mark Murcko, Ph.D. to the Board of Bind Research and our Lead Scientific Advisor. Mark joins Tom Kalil, who was recently appointed Interim Chair of the Board. Tom is CEO of Renaissance Philanthropy, an organisation that has already played a vital role in Bind’s establishment. Mark brings to Bind a deep […]

28 Apr 2026

News updates

Bind opens its Submit a Target initiative

Got an IDP target? We’d love to hear from you. Intrinsically disordered proteins are implicated in some of the most important and least-treated diseases in human health, but for a long time the tools to drug them simply didn’t exist. At Bind, we’re building those tools, and we want to put them to work on […]

19 Mar 2026